Cheryl Barton

home / authors / cheryl-barton

Cheryl Barton is director of PharmaVision, info@pharmavision.co.uk.

Articles

European union DNA | Image Credit: ©Kestutis - Stock.adobe.com

Frontrunners in Automated Cell and Gene Therapy Manufacturing

Cheryl Barton
September 28th 2024

Innovative solutions are making personalized cell and gene therapies accessible to all.

Site Logo

Building a New Arsenal of Therapeutics from Oncolytic Viruses

Cheryl Barton
October 11th 2023

New routes to cancer treatment can be found with the help of tumor-infiltrating lymphocyte (TIL) therapies.

Landkarte *** Europa | Image Credit: © beugdesign - © beugdesign - Stock.adobe.com

Phasing Out COVID-19 Regulatory Flexibilities

Cheryl Barton
September 22nd 2023

What impact will EMA’s decision to phase out COVID-19 regulatory flexibilities have on the pharma industry?

Oncolytic Virus immunotherapy and cancer vaccine Therapy as a treatment to kill cancers by attacking the malignant tumor cell and infecting them and destroying the pathogen | Image Credit: © freshidea - Stock.adobe.com

Harnessing the Power of Oncolytic Viruses

Cheryl Barton
September 20th 2023

Tumour-infiltrating lymphocyte (TIL) therapies offer a new route to target cancer.

Creative image of embryonic stem cells, cellular therapy. 3d illustration | Image Credit: © pinkeyes- stock.adobe.com

Frontrunners in the Latest Stem Cell Technology

Cheryl Barton
March 23rd 2023

TreeFrog Therapeutics is leaping ahead in cell therapies through resources such as new technologies and investor partnerships.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: November 15th 2024 | Updated: November 21st 2024
Solving Challenges with AAV Aggregate Analysis Using a Novel Size Exclusion Particle to Determine CQAs
Published: October 28th 2024 | Updated: November 21st 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 22nd 2024 | Updated: November 21st 2024
Optimizing cGMP Facility Design Space with a Hybrid Approach
Published: October 28th 2024 | Updated: November 21st 2024
Quantifying Chemotherapeutic Cytotoxicity in Glial Cells using AI-Driven Label-Free Cell Analysis
© 2024 MJH Life Sciences

All rights reserved.